ERBB2 and breast cancer: Given the fact that few studies investigated the value of NLR and CAR as prognostic markers for luminal BC with HER2-negativity, we attempted to investigate the predictive value of NLR and CAR on DFS and CSS for luminal BC patients with HER2-negativity by univariate and multivariate analyses.